Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5928464 | American Heart Journal | 2014 | 30 Pages |
Abstract
PA32540 reduced the incidence of endoscopic GUs compared to EC-ASA 325 mg, but with a similar cardiovascular event profile. Due to fewer UGI symptoms, continuation on aspirin therapy was greater in the PA32540 treatment arm.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David J. MD, Jay L. MD, Byron L. MD, Glenn M. MD, Angel MD, Alan B. MD, James M. MD, John G. MD, Ying MS, Christopher MD,